Drugmakers have to jump through several research and regulatory hoops before their treatments can reach pharmacy counters and store shelves. While pharmaceutical giants manage those challenges in-house, smaller companies outsource that work to companies like the Wednesday IBD 50 Growth Stock To Watch pick Medpace Holdings (MEDP). Shares of the medical research contractor soared to an all-time high after second-quarter…
Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8